<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37243816</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>11</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1559-1182</ISSN><JournalIssue CitedMedium="Internet"><Volume>60</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Molecular neurobiology</Title><ISOAbbreviation>Mol Neurobiol</ISOAbbreviation></Journal><ArticleTitle>The E3 Ubiquitin Ligase SCF Cyclin F Promotes Sequestosome-1/p62 Insolubility and Foci Formation and is Dysregulated in ALS and FTD Pathogenesis.</ArticleTitle><Pagination><StartPage>5034</StartPage><EndPage>5054</EndPage><MedlinePgn>5034-5054</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12035-023-03355-2</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS)- and frontotemporal dementia (FTD)-linked mutations in CCNF have been shown to cause dysregulation to protein homeostasis. CCNF encodes for cyclin F, which is part of the cyclin F-E3 ligase complex SCF<sup>cyclinF</sup> known to ubiquitylate substrates for proteasomal degradation. In this study, we identified a function of cyclin F to regulate substrate solubility and show how cyclin F mechanistically underlies ALS and FTD disease pathogenesis. We demonstrated that ALS and FTD-associated protein sequestosome-1/p62 (p62) was a canonical substrate of cyclin F which was ubiquitylated by the SCF<sup>cyclinF</sup> complex. We found that SCF<sup>cyclin F</sup> ubiquitylated p62 at lysine(K)281, and that K281 regulated the propensity of p62 to aggregate. Further, cyclin F expression promoted the aggregation of p62 into the insoluble fraction, which corresponded to an increased number of p62 foci. Notably, ALS and FTD-linked mutant cyclin F p.S621G aberrantly ubiquitylated p62, dysregulated p62 solubility in neuronal-like cells, patient-derived fibroblasts and induced pluripotent stem cells and dysregulated p62 foci formation. Consistently, motor neurons from patient spinal cord tissue exhibited increased p62 ubiquitylation. We suggest that the p.S621G mutation impairs the functions of cyclin F to promote p62 foci formation and shift p62 into the insoluble fraction, which may be associated to aberrant mutant cyclin F-mediated ubiquitylation of p62. Given that p62 dysregulation is common across the ALS and FTD spectrum, our study provides insights into p62 regulation and demonstrates that ALS and FTD-linked cyclin F mutant p.S621G can drive p62 pathogenesis associated with ALS and FTD.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Davidson</LastName><ForeName>Jennilee M</ForeName><Initials>JM</Initials><Identifier Source="ORCID">0000-0002-7996-1386</Identifier><AffiliationInfo><Affiliation>Centre for Motor Neuron Disease Research, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Level 1, 75 Talavera Road, Sydney, NSW, 2109, Australia. jennilee.davidson@mq.edu.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Sharlynn S L</ForeName><Initials>SSL</Initials><AffiliationInfo><Affiliation>Centre for Motor Neuron Disease Research, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Level 1, 75 Talavera Road, Sydney, NSW, 2109, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rayner</LastName><ForeName>Stephanie L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Centre for Motor Neuron Disease Research, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Level 1, 75 Talavera Road, Sydney, NSW, 2109, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Flora</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Centre for Motor Neuron Disease Research, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Level 1, 75 Talavera Road, Sydney, NSW, 2109, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duncan</LastName><ForeName>Kimberley</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Centre for Motor Neuron Disease Research, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Level 1, 75 Talavera Road, Sydney, NSW, 2109, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Russo</LastName><ForeName>Carlo</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Computational NeuroSurgery (CNS) Lab, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Level 1, 75 Talavera Road, Sydney, NSW, 2109, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Newbery</LastName><ForeName>Michelle</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Illawarra Health and Medical Research Institute, Northfields Avenue, Wollongong, NSW, 2522, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Chemistry and Molecular Bioscience and Molecular Horizons, University of Wollongong, Northfields Avenue, Wollongong, NSW, 2522, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Kunjie</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Centre for Motor Neuron Disease Research, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Level 1, 75 Talavera Road, Sydney, NSW, 2109, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scherer</LastName><ForeName>Natalie M</ForeName><Initials>NM</Initials><AffiliationInfo><Affiliation>Centre for Motor Neuron Disease Research, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Level 1, 75 Talavera Road, Sydney, NSW, 2109, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balez</LastName><ForeName>Rachelle</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Illawarra Health and Medical Research Institute, Northfields Avenue, Wollongong, NSW, 2522, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Chemistry and Molecular Bioscience and Molecular Horizons, University of Wollongong, Northfields Avenue, Wollongong, NSW, 2522, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a-Redondo</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Raras (CIBERER U-723), Unidad de ELA, Instituto de Investigaci&#xf3;n Hospital 12 de Octubre de Madrid, SERMAS, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>R&#xe1;bano</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Neuropathology Department and CIEN Tissue Bank, Alzheimer's Centre Reina Sofia-CIEN Foundation, 28031, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosa-Fernandes</LastName><ForeName>Livia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Centre for Motor Neuron Disease Research, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Level 1, 75 Talavera Road, Sydney, NSW, 2109, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ooi</LastName><ForeName>Lezanne</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Illawarra Health and Medical Research Institute, Northfields Avenue, Wollongong, NSW, 2522, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Chemistry and Molecular Bioscience and Molecular Horizons, University of Wollongong, Northfields Avenue, Wollongong, NSW, 2522, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Kelly L</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Centre for Motor Neuron Disease Research, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Level 1, 75 Talavera Road, Sydney, NSW, 2109, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morsch</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centre for Motor Neuron Disease Research, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Level 1, 75 Talavera Road, Sydney, NSW, 2109, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blair</LastName><ForeName>Ian P</ForeName><Initials>IP</Initials><AffiliationInfo><Affiliation>Centre for Motor Neuron Disease Research, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Level 1, 75 Talavera Road, Sydney, NSW, 2109, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Ieva</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Computational NeuroSurgery (CNS) Lab, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Level 1, 75 Talavera Road, Sydney, NSW, 2109, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Shu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centre for Motor Neuron Disease Research, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Level 1, 75 Talavera Road, Sydney, NSW, 2109, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chung</LastName><ForeName>Roger S</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>Centre for Motor Neuron Disease Research, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Level 1, 75 Talavera Road, Sydney, NSW, 2109, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Albert</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre for Motor Neuron Disease Research, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Level 1, 75 Talavera Road, Sydney, NSW, 2109, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>IG1910</GrantID><Agency>Motor Neurone Disease Research Australia</Agency><Country/></Grant><Grant><GrantID>IG2029</GrantID><Agency>Motor Neurone Disease Research Australia</Agency><Country/></Grant><Grant><GrantID>IG2036</GrantID><Agency>Motor Neurone Disease Research Australia</Agency><Country/></Grant><Grant><GrantID>IG2221</GrantID><Agency>Motor Neurone Disease Research Australia</Agency><Country/></Grant><Grant><GrantID>Phyllis Diana Seman MND Research Grant</GrantID><Agency>Motor Neurone Disease Research Australia</Agency><Country/></Grant><Grant><GrantID>BLP1901</GrantID><Agency>Motor Neurone Disease Research Australia</Agency><Country/></Grant><Grant><GrantID>IG2308</GrantID><Agency>Motor Neurone Disease Research Australia</Agency><Country/></Grant><Grant><GrantID>APP1095215</GrantID><Agency>National Health and Medical Research Council</Agency><Country/></Grant><Grant><GrantID>APP1107644</GrantID><Agency>National Health and Medical Research Council</Agency><Country/></Grant><Grant><GrantID>APP1176913</GrantID><Agency>National Health and Medical Research Council</Agency><Country/></Grant><Grant><GrantID>APP2020035</GrantID><Agency>National Health and Medical Research Council</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mol Neurobiol</MedlineTA><NlmUniqueID>8900963</NlmUniqueID><ISSNLinking>0893-7648</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 2.3.2.27</RegistryNumber><NameOfSubstance UI="D044767">Ubiquitin-Protein Ligases</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016213">Cyclins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044767" MajorTopicYN="N">Ubiquitin-Protein Ligases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016213" MajorTopicYN="N">Cyclins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054875" MajorTopicYN="N">Ubiquitination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Aggregation</Keyword><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Cyclin F</Keyword><Keyword MajorTopicYN="N">Frontotemporal dementia</Keyword><Keyword MajorTopicYN="N">Sequestosome-1/p62</Keyword><Keyword MajorTopicYN="N">Ubiquitylation</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>11</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>27</Day><Hour>19</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>27</Day><Hour>15</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37243816</ArticleId><ArticleId IdType="pmc">PMC10415446</ArticleId><ArticleId IdType="doi">10.1007/s12035-023-03355-2</ArticleId><ArticleId IdType="pii">10.1007/s12035-023-03355-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Blokhuis AM, Groen EJN, Koppers M, van den Berg LH, Pasterkamp RJ. Protein aggregation in amyotrophic lateral sclerosis. Acta Neuropathol. 2013;125(6):777&#x2013;794. doi: 10.1007/s00401-013-1125-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1125-6</ArticleId><ArticleId IdType="pmc">PMC3661910</ArticleId><ArticleId IdType="pubmed">23673820</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams KL, et al. CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia. Nat Commun. 2016 doi: 10.1038/ncomms11253.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms11253</ArticleId><ArticleId IdType="pmc">PMC4835537</ArticleId><ArticleId IdType="pubmed">27080313</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian D, Li J, Tang L, Zhang N, Fan D (2018) Screening for CCNF mutations in a Chinese amyotrophic lateral sclerosis cohort. Front Aging Neurosci 10. 10.3389/fnagi.2018.00185</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6034086</ArticleId><ArticleId IdType="pubmed">30008669</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai C, Richman R, Elledge SJ. Human cyclin F. EMBO J. 1994 doi: 10.1002/j.1460-2075.1994.tb06955.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/j.1460-2075.1994.tb06955.x</ArticleId><ArticleId IdType="pmc">PMC395587</ArticleId><ArticleId IdType="pubmed">7813445</ArticleId></ArticleIdList></Reference><Reference><Citation>Galper J, et al. Cyclin F: a component of an E3 ubiquitin ligase complex with roles in neurodegeneration and cancer. Int J Biochem Cell Biol. 2017 doi: 10.1016/j.biocel.2017.06.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biocel.2017.06.011</ArticleId><ArticleId IdType="pubmed">28652210</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulman BA, Lindstrom DL, Harlow E. Substrate recruitment to cyclin-dependent kinase 2 by a multipurpose docking site on cyclin A. Proc Natl Acad Sci U S A. 1998 doi: 10.1073/pnas.95.18.10453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.95.18.10453</ArticleId><ArticleId IdType="pmc">PMC27915</ArticleId><ArticleId IdType="pubmed">9724724</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Angiolella V, et al. SCF(Cyclin F) controls centrosome homeostasis and mitotic fidelity through CP110 degradation. Nature. 2010;466(7302):138&#x2013;142. doi: 10.1038/nature09140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09140</ArticleId><ArticleId IdType="pmc">PMC2946399</ArticleId><ArticleId IdType="pubmed">20596027</ArticleId></ArticleIdList></Reference><Reference><Citation>Emanuele MJ, et al. Global identification of modular cullin-RING ligase substrates. Cell. 2011 doi: 10.1016/j.cell.2011.09.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2011.09.019</ArticleId><ArticleId IdType="pmc">PMC3226719</ArticleId><ArticleId IdType="pubmed">21963094</ArticleId></ArticleIdList></Reference><Reference><Citation>Walter D, Hoffmann S, Komseli E-S, Rappsilber J, Gorgoulis V, S&#xf8;rensen CS. SCF(Cyclin F)-dependent degradation of CDC6 suppresses DNA re-replication. Nat Commun. 2016;7:10530. doi: 10.1038/ncomms10530.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms10530</ArticleId><ArticleId IdType="pmc">PMC4738361</ArticleId><ArticleId IdType="pubmed">26818844</ArticleId></ArticleIdList></Reference><Reference><Citation>Dankert JF, et al. Cyclin F-mediated degradation of SLBP limits H2A.X accumulation and apoptosis upon genotoxic stress in G2. Mol Cell. 2016 doi: 10.1016/j.molcel.2016.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2016.09.010</ArticleId><ArticleId IdType="pmc">PMC5097008</ArticleId><ArticleId IdType="pubmed">27773672</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Angiolella V, et al. Cyclin F-mediated degradation of ribonucleotide reductase M2 controls genome integrity and DNA repair. Cell. 2012;149(5):1023&#x2013;1034. doi: 10.1016/j.cell.2012.03.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2012.03.043</ArticleId><ArticleId IdType="pmc">PMC3616325</ArticleId><ArticleId IdType="pubmed">22632967</ArticleId></ArticleIdList></Reference><Reference><Citation>Clijsters L, et al. Cyclin F controls cell-cycle transcriptional outputs by directing the degradation of the three activator E2Fs. Mol Cell. 2019 doi: 10.1016/j.molcel.2019.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2019.04.010</ArticleId><ArticleId IdType="pmc">PMC6588466</ArticleId><ArticleId IdType="pubmed">31130363</ArticleId></ArticleIdList></Reference><Reference><Citation>Burdova K et al (2019) E2F1 proteolysis via SCF &#x2010;cyclin F underlies synthetic lethality between cyclin F loss and Chk1 inhibition. EMBO J. 10.15252/embj.2018101443</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6792013</ArticleId><ArticleId IdType="pubmed">31424118</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan R et al (2019) Cyclin F&#x2010;dependent degradation of E2F7 is critical for DNA repair and G2&#x2010;phase progression. EMBO J. 10.15252/embj.2018101430</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6792010</ArticleId><ArticleId IdType="pubmed">31475738</ArticleId></ArticleIdList></Reference><Reference><Citation>Elia AEH, et al. Quantitative proteomic atlas of ubiquitination and acetylation in the DNA damage response. Mol Cell. 2015 doi: 10.1016/j.molcel.2015.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2015.05.006</ArticleId><ArticleId IdType="pmc">PMC4560960</ArticleId><ArticleId IdType="pubmed">26051181</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhury R, et al. APC/C and SCFcyclin F constitute a reciprocal feedback circuit controlling S-phase entry. Cell Rep. 2016 doi: 10.1016/j.celrep.2016.08.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2016.08.058</ArticleId><ArticleId IdType="pmc">PMC5111906</ArticleId><ArticleId IdType="pubmed">27653696</ArticleId></ArticleIdList></Reference><Reference><Citation>Deshmukh RS, Sharma S, Das S. Cyclin F-dependent degradation of RBPJ inhibits IDH1R132H-mediated tumorigenesis. Cancer Res. 2018 doi: 10.1158/0008-5472.CAN-18-1772.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-18-1772</ArticleId><ArticleId IdType="pubmed">30254149</ArticleId></ArticleIdList></Reference><Reference><Citation>Mills CA et al (2020) Sirtuin 5 is regulated by the SCF-Cyclin F ubiquitin ligase and is involved in cell cycle control. Mol Cell Biol 41(2):e00269&#x2013;20. 10.1128/MCB.00269-20</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8093487</ArticleId><ArticleId IdType="pubmed">33168699</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee A et al (2017) Casein kinase II phosphorylation of cyclin F at serine 621 regulates the Lys48-ubiquitylation E3 ligase activity of the SCF(cyclin F)complex. Open Biol 7(10):170058. 10.1098/rsob.170058</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5666078</ArticleId><ArticleId IdType="pubmed">29021214</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee A, et al. Pathogenic mutation in the ALS/FTD gene, CCNF, causes elevated Lys48-linked ubiquitylation and defective autophagy. Cell Mol Life Sci. 2018;75(2):335&#x2013;354. doi: 10.1007/s00018-017-2632-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-017-2632-8</ArticleId><ArticleId IdType="pubmed">28852778</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng F, et al. Unbiased label-free quantitative proteomics of cells expressing amyotrophic lateral sclerosis (ALS) mutations in CCNF reveals activation of the apoptosis pathway: a workflow to screen pathogenic gene mutations. Front Mol Neurosci. 2021;14:59. doi: 10.3389/fnmol.2021.627740.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2021.627740</ArticleId><ArticleId IdType="pmc">PMC8111008</ArticleId><ArticleId IdType="pubmed">33986643</ArticleId></ArticleIdList></Reference><Reference><Citation>Rayner SL, et al. TDP-43 is a ubiquitylation substrate of the SCFcyclin F complex. Neurobiol Dis. 2022;167:105673. doi: 10.1016/J.NBD.2022.105673.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.NBD.2022.105673</ArticleId><ArticleId IdType="pubmed">35231559</ArticleId></ArticleIdList></Reference><Reference><Citation>Rayner SL, et al. ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ. Hum Mol Genet. 2021 doi: 10.1093/hmg/ddab073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddab073</ArticleId><ArticleId IdType="pubmed">33729478</ArticleId></ArticleIdList></Reference><Reference><Citation>Hogan AL, et al. Expression of ALS/FTD-linked mutant CCNF in zebrafish leads to increased cell death in the spinal cord and an aberrant motor phenotype. Hum Mol Genet. 2017;26(14):2616&#x2013;2626. doi: 10.1093/hmg/ddx136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx136</ArticleId><ArticleId IdType="pubmed">28444311</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y, et al. Pathogenic mutations in the ALS gene CCNF cause cytoplasmic mislocalization of Cyclin F and elevated VCP ATPase activity. Hum Mol Genet. 2019 doi: 10.1093/hmg/ddz119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddz119</ArticleId><ArticleId IdType="pubmed">31577344</ArticleId></ArticleIdList></Reference><Reference><Citation>Rayner SL et al (2022) Cyclin F, neurodegeneration, and the pathogenesis of ALS/FTD. Neuroscientist, p 107385842211201. 10.1177/10738584221120182</Citation><ArticleIdList><ArticleId IdType="pubmed">36062310</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakano T, Nakaso K, Nakashima K, Ohama E. Expression of ubiquitin-binding protein p62 in ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis with dementia: analysis of five autopsy cases with broad clinicopathological spectrum. Acta Neuropathol. 2004;107(4):359&#x2013;364. doi: 10.1007/S00401-004-0821-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S00401-004-0821-7</ArticleId><ArticleId IdType="pubmed">14762676</ArticleId></ArticleIdList></Reference><Reference><Citation>Hiji Masanori M, Takahashi T, Fukuba H, Yamashita H, Kohriyama T, Matsumoto M. White matter lesions in the brain with frontotemporal lobar degeneration with motor neuron disease: TDP-43-immunopositive inclusions co-localize with p62, but not ubiquitin. Acta Neuropathol. 2008;116(2):183&#x2013;191. doi: 10.1007/s00401-008-0402-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-008-0402-2</ArticleId><ArticleId IdType="pubmed">18584184</ArticleId></ArticleIdList></Reference><Reference><Citation>Fecto F, et al. SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis. Arch Neurol. 2011;68(11):1440&#x2013;1446. doi: 10.1001/archneurol.2011.250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2011.250</ArticleId><ArticleId IdType="pubmed">22084127</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng HX, et al. FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis. Ann Neurol. 2010;67(6):739&#x2013;748. doi: 10.1002/ana.22051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.22051</ArticleId><ArticleId IdType="pmc">PMC4376270</ArticleId><ArticleId IdType="pubmed">20517935</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YP, et al. SQSTM1 mutations in Han Chinese populations with sporadic amyotrophic lateral sclerosis. Neurobiol Aging. 2014;35(3):726.e7&#x2013;726.e9. doi: 10.1016/j.neurobiolaging.2013.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2013.09.008</ArticleId><ArticleId IdType="pubmed">24138988</ArticleId></ArticleIdList></Reference><Reference><Citation>Teyssou E, et al. Mutations in SQSTM1 encoding p62 in amyotrophic lateral sclerosis: Genetics and neuropathology. Acta Neuropathol. 2013;125(4):511&#x2013;522. doi: 10.1007/s00401-013-1090-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1090-0</ArticleId><ArticleId IdType="pubmed">23417734</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu H, et al. Sporadic ALS with compound heterozygous mutations in the SQSTM1 gene. Acta Neuropathol. 2013;3:453&#x2013;459. doi: 10.1007/s00401-013-1150-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1150-5</ArticleId><ArticleId IdType="pubmed">23812289</ArticleId></ArticleIdList></Reference><Reference><Citation>Davidson JM, Chung RS, Lee A. The converging roles of sequestosome-1/p62 in the molecular pathways of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) Neurobiol Dis. 2022;166:105653. doi: 10.1016/J.NBD.2022.105653.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.NBD.2022.105653</ArticleId><ArticleId IdType="pubmed">35143965</ArticleId></ArticleIdList></Reference><Reference><Citation>Foster A, Rea S. The role of sequestosome 1/p62 protein in amyotrophic lateral sclerosis and frontotemporal dementia pathogenesis. Neural Regen Res. 2020 doi: 10.4103/1673-5374.284977.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.284977</ArticleId><ArticleId IdType="pmc">PMC7749485</ArticleId><ArticleId IdType="pubmed">32594029</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu WJ, et al. p62 links the autophagy pathway and the ubiqutin-proteasome system upon ubiquitinated protein degradation. Cell Mol Biol Lett. 2016 doi: 10.1186/s11658-016-0031-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s11658-016-0031-z</ArticleId><ArticleId IdType="pmc">PMC5415757</ArticleId><ArticleId IdType="pubmed">28536631</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin X, et al. Interaction domains of p62: a bridge between p62 and selective autophagy. DNA Cell Biol. 2013 doi: 10.1089/dna.2012.1915.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/dna.2012.1915</ArticleId><ArticleId IdType="pubmed">23530606</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamark T, et al. Interaction codes within the family of mammalian Phox and Bem1p domain-containing proteins. J Biol Chem. 2003 doi: 10.1074/jbc.M303221200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M303221200</ArticleId><ArticleId IdType="pubmed">12813044</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumoto G, Wada K, Okuno M, Kurosawa M, Nukina N. Serine 403 phosphorylation of p62/SQSTM1 regulates selective autophagic clearance of ubiquitinated proteins. Mol Cell. 2011;44(2):279&#x2013;289. doi: 10.1016/j.molcel.2011.07.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2011.07.039</ArticleId><ArticleId IdType="pubmed">22017874</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumoto G, Shimogori T, Hattori N, Nukina N. TBK1 controls autophagosomal engulfment of polyubiquitinated mitochondria through p62/SQSTM1 phosphorylation. Hum Mol Genet. 2015;24(15):4429&#x2013;4442. doi: 10.1093/hmg/ddv179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddv179</ArticleId><ArticleId IdType="pubmed">25972374</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim J, et al. Proteotoxic stress induces phosphorylation of p62/SQSTM1 by ULK1 to regulate selective autophagic clearance of protein aggregates. PLoS Genet. 2015 doi: 10.1371/journal.pgen.1004987.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1004987</ArticleId><ArticleId IdType="pmc">PMC4344198</ArticleId><ArticleId IdType="pubmed">25723488</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilli M, et al. TBK-1 promotes autophagy-mediated antimicrobial defense by controlling autophagosome maturation. Immunity. 2012;37(2):223&#x2013;234. doi: 10.1016/j.immuni.2012.04.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2012.04.015</ArticleId><ArticleId IdType="pmc">PMC3428731</ArticleId><ArticleId IdType="pubmed">22921120</ArticleId></ArticleIdList></Reference><Reference><Citation>Heath RJ, et al. RNF166 determines recruitment of adaptor proteins during antibacterial autophagy. Cell Rep. 2016 doi: 10.1016/j.celrep.2016.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2016.11.005</ArticleId><ArticleId IdType="pmc">PMC5192565</ArticleId><ArticleId IdType="pubmed">27880896</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan JA, et al. TRIM21 ubiquitylates SQSTM1/p62 and suppresses protein sequestration to regulate redox homeostasis. Mol Cell. 2016;61(5):720. doi: 10.1016/J.MOLCEL.2016.02.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.MOLCEL.2016.02.007</ArticleId><ArticleId IdType="pmc">PMC4779181</ArticleId><ArticleId IdType="pubmed">26942676</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YJ, Chou TF, Pittman SK, Keith AL, Razani B, Weihl CC. Keap1/Cullin3 modulates p62/SQSTM1 activity via UBA domain ubiquitination. Cell Rep. 2017;19(1):188&#x2013;202. doi: 10.1016/j.celrep.2017.03.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.03.030</ArticleId><ArticleId IdType="pmc">PMC5395095</ArticleId><ArticleId IdType="pubmed">28380357</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Q, et al. The HECT E3 ubiquitin ligase NEDD4 interacts with and ubiquitylates SQSTM1 for inclusion body autophagy. J Cell Sci. 2017 doi: 10.1242/jcs.207068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.207068</ArticleId><ArticleId IdType="pubmed">29021346</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein DK, et al. Cyclin F suppresses B-Myb activity to promote cell cycle checkpoint control. Nat Commun. 2015;6:5800. doi: 10.1038/ncomms6800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms6800</ArticleId><ArticleId IdType="pubmed">25557911</ArticleId></ArticleIdList></Reference><Reference><Citation>Alam MS. Proximity ligation assay (PLA) Curr Protoc Immunol. 2018 doi: 10.1002/cpim.58.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpim.58</ArticleId><ArticleId IdType="pmc">PMC6205916</ArticleId><ArticleId IdType="pubmed">30238640</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng H, et al. Ubiquitylation of p62/sequestosome1 activates its autophagy receptor function and controls selective autophagy upon ubiquitin stress. Cell Res. 2017 doi: 10.1038/cr.2017.40.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2017.40</ArticleId><ArticleId IdType="pmc">PMC5520855</ArticleId><ArticleId IdType="pubmed">28322253</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornbeck PV, Zhang B, Murray B, Kornhauser JM, Latham V, Skrzypek E. PhosphoSitePlus, 2014: Mutations. PTMs and recalibrations: Nucleic Acids Res; 2015.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4383998</ArticleId><ArticleId IdType="pubmed">25514926</ArticleId></ArticleIdList></Reference><Reference><Citation>Bax M, et al. Generation and characterization of a human induced pluripotent stem cell line UOWi005-A from dermal fibroblasts derived from a CCNFS621G familial amyotrophic lateral sclerosis patient using mRNA reprogramming. Stem Cell Res. 2019 doi: 10.1016/j.scr.2019.101530.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scr.2019.101530</ArticleId><ArticleId IdType="pubmed">31445393</ArticleId></ArticleIdList></Reference><Reference><Citation>Danieli A, Martens S. P62 - Mediated phase separation at the intersection of the ubiquitin-Proteasome system and autophagy. J Cell Sci. 2018 doi: 10.1242/jcs.214304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.214304</ArticleId><ArticleId IdType="pmc">PMC7610772</ArticleId><ArticleId IdType="pubmed">30287680</ArticleId></ArticleIdList></Reference><Reference><Citation>Kocaturk NM, Gozuacik D. Crosstalk between mammalian autophagy and the ubiquitin-proteasome system. Front Cell Dev Biol. 2018 doi: 10.3389/fcell.2018.00128.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2018.00128</ArticleId><ArticleId IdType="pmc">PMC6175981</ArticleId><ArticleId IdType="pubmed">30333975</ArticleId></ArticleIdList></Reference><Reference><Citation>Pohl C, Dikic I. Cellular quality control by the ubiquitin-proteasome system and autophagy. Science. 2019 doi: 10.1126/science.aax3769.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aax3769</ArticleId><ArticleId IdType="pubmed">31727826</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Angiolella V, Esencay M, Pagano M. A cyclin without cyclin-dependent kinases: cyclin F controls genome stability through ubiquitin-mediated proteolysis. Trends Cell Biol. 2013;23(3):135&#x2013;140. doi: 10.1016/j.tcb.2012.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2012.10.011</ArticleId><ArticleId IdType="pmc">PMC3597434</ArticleId><ArticleId IdType="pubmed">23182110</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng H, et al. Ubiquitylation of p62/sequestosome1 activates its autophagy receptor function and controls selective autophagy upon ubiquitin stress. Cell Res. 2017;27(5):657&#x2013;674. doi: 10.1038/cr.2017.40.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2017.40</ArticleId><ArticleId IdType="pmc">PMC5520855</ArticleId><ArticleId IdType="pubmed">28322253</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, et al. The multistep hypothesis of ALS revisited. Neurology. 2018;91(7):e635&#x2013;e642. doi: 10.1212/WNL.0000000000005996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000005996</ArticleId><ArticleId IdType="pmc">PMC6105040</ArticleId><ArticleId IdType="pubmed">30045958</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A, et al. Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study. Lancet Neurol. 2014;13(11):1108&#x2013;1113. doi: 10.1016/S1474-4422(14)70219-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(14)70219-4</ArticleId><ArticleId IdType="pmc">PMC4197338</ArticleId><ArticleId IdType="pubmed">25300936</ArticleId></ArticleIdList></Reference><Reference><Citation>Vucic S, Westeneng HJ, Al-Chalabi A, van den Berg LH, Talman P, Kiernan MC. Amyotrophic lateral sclerosis as a multi-step process: an Australia population study. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20(7&#x2013;8):532&#x2013;537. doi: 10.1080/21678421.2018.1556697.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1556697</ArticleId><ArticleId IdType="pubmed">31284763</ArticleId></ArticleIdList></Reference><Reference><Citation>Song P, et al. Parkin promotes proteasomal degradation of p62: implication of selective vulnerability of neuronal cells in the pathogenesis of Parkinson&#x2019;s disease. Protein Cell. 2016 doi: 10.1007/s13238-015-0230-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-015-0230-9</ArticleId><ArticleId IdType="pmc">PMC4742389</ArticleId><ArticleId IdType="pubmed">26746706</ArticleId></ArticleIdList></Reference><Reference><Citation>Siebert A, Gattringer V, Weishaupt JH, Behrends C (2022) ALS-linked loss of Cyclin-F function affects HSP90. Life Sci Alliance 5(12):e202101359. 10.26508/lsa.202101359</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9481933</ArticleId><ArticleId IdType="pubmed">36114006</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J, et al. Autophagy suppresses interleukin-1&#x3b2; (IL-1&#x3b2;) signaling by activation of p62 degradation via lysosomal and proteasomal pathways. J Biol Chem. 2012;287(6):4033&#x2013;4040. doi: 10.1074/jbc.M111.280065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.280065</ArticleId><ArticleId IdType="pmc">PMC3281713</ArticleId><ArticleId IdType="pubmed">22167182</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan JA, et al. TRIM21 ubiquitylates SQSTM1/p62 and suppresses protein sequestration to regulate redox homeostasis. Mol Cell. 2016 doi: 10.1016/j.molcel.2016.02.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2016.02.007</ArticleId><ArticleId IdType="pmc">PMC4779181</ArticleId><ArticleId IdType="pubmed">26942676</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan JA, et al. Corrections to "TRIM21 ubiquitylates SQSTM1/p62 and suppresses protein sequestration to regulate redox homeostasis. Mol Cell. 2016;61:720&#x2013;33. doi: 10.1016/j.molcel.2016.03.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2016.03.015</ArticleId><ArticleId IdType="pmc">PMC4779181</ArticleId><ArticleId IdType="pubmed">26942676</ArticleId></ArticleIdList></Reference><Reference><Citation>Yerbury JJ, Farrawell NE, McAlary L. Proteome homeostasis dysfunction: a unifying principle in ALS pathogenesis. Trends Neurosci. 2020 doi: 10.1016/j.tins.2020.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2020.03.002</ArticleId><ArticleId IdType="pubmed">32353332</ArticleId></ArticleIdList></Reference><Reference><Citation>Saitoh Y, Nagai Y (2017) Commentary Open Access Commentary: p62 plays a protective role in the autophagic degradation of polyglutamine protein oligomers in polyglutamine disease model flies. Dis Res Treat 2(3):7&#x2013;10. [Online]. Available: www.rarediseasesjournal.com. Accessed 19 May 2022</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4340391</ArticleId><ArticleId IdType="pubmed">25480790</ArticleId></ArticleIdList></Reference><Reference><Citation>Khaminets A, Behl C, Dikic I. Ubiquitin-dependent and independent signals in selective autophagy. Trends Cell Biol. 2016;26(1):6&#x2013;16. doi: 10.1016/J.TCB.2015.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.TCB.2015.08.010</ArticleId><ArticleId IdType="pubmed">26437584</ArticleId></ArticleIdList></Reference><Reference><Citation>Bj&#xf8;rk&#xf8;y G, et al. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J Cell Biol. 2005 doi: 10.1083/jcb.200507002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200507002</ArticleId><ArticleId IdType="pmc">PMC2171557</ArticleId><ArticleId IdType="pubmed">16286508</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun D, Wu R, Zheng J, Li P, Yu L. Polyubiquitin chain-induced p62 phase separation drives autophagic cargo segregation. Cell Res. 2018;28(4):405&#x2013;415. doi: 10.1038/s41422-018-0017-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-018-0017-7</ArticleId><ArticleId IdType="pmc">PMC5939046</ArticleId><ArticleId IdType="pubmed">29507397</ArticleId></ArticleIdList></Reference><Reference><Citation>Gal J, Str&#xf6;m AL, Kilty R, Zhang F, Zhu H. p62 accumulates and enhances aggregate formation in model systems of familial amyotrophic lateral sclerosis. J Biol Chem. 2007 doi: 10.1074/jbc.M608787200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M608787200</ArticleId><ArticleId IdType="pubmed">17296612</ArticleId></ArticleIdList></Reference><Reference><Citation>Paine MG, Babu JR, Seibenhener ML, Wooten MW. Evidence for p62 aggregate formation: role in cell survival. FEBS Lett. 2005;579(22):5029&#x2013;5034. doi: 10.1016/J.FEBSLET.2005.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.FEBSLET.2005.08.010</ArticleId><ArticleId IdType="pubmed">16129434</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson MI, Gill DJ, Perisic O, Quinn MT, Williams RL. PB1 domain-mediated heterodimerization in NADPH oxidase and signaling complexes of atypical protein kinase C with Par6 and p62. Mol Cell. 2003;12(1):39&#x2013;50. doi: 10.1016/S1097-2765(03)00246-6/ATTACHMENT/670E876D-2E33-454D-BAB1-6F62D4D6B450/MMC5.JPG.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1097-2765(03)00246-6/ATTACHMENT/670E876D-2E33-454D-BAB1-6F62D4D6B450/MMC5.JPG</ArticleId><ArticleId IdType="pubmed">12887891</ArticleId></ArticleIdList></Reference><Reference><Citation>Foster AD, et al. p62 overexpression induces TDP-43 cytoplasmic mislocalisation, aggregation and cleavage and neuronal death. Sci Rep. 2021;11(1):11474. doi: 10.1038/s41598-021-90822-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-90822-2</ArticleId><ArticleId IdType="pmc">PMC8169680</ArticleId><ArticleId IdType="pubmed">34075102</ArticleId></ArticleIdList></Reference><Reference><Citation>Young JA, et al. Fas-associated death domain (FADD) and the E3 ubiquitin-protein ligase TRIM21 interact to negatively regulate virus-induced interferon production. J Biol Chem. 2011;286(8):6521&#x2013;6531. doi: 10.1074/JBC.M110.172288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/JBC.M110.172288</ArticleId><ArticleId IdType="pmc">PMC3057824</ArticleId><ArticleId IdType="pubmed">21183682</ArticleId></ArticleIdList></Reference><Reference><Citation>Davidson JM, Wong CT, Rai-Bhogal R, Li H, Crawford DA. Prostaglandin E2 elevates calcium in differentiated neuroectodermal stem cells. Mol Cell Neurosci. 2016;74:71&#x2013;77. doi: 10.1016/j.mcn.2016.03.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2016.03.010</ArticleId><ArticleId IdType="pubmed">27074429</ArticleId></ArticleIdList></Reference><Reference><Citation>Davidson JM, Wong CT, Li H, Crawford DA. Prostaglandin E2 facilitates subcellular translocation of the EP4 receptor in neuroectodermal NE-4C stem cells. Biochem Biophys Rep. 2016;7:173&#x2013;179. doi: 10.1016/j.bbrep.2016.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrep.2016.06.001</ArticleId><ArticleId IdType="pmc">PMC5613302</ArticleId><ArticleId IdType="pubmed">28955904</ArticleId></ArticleIdList></Reference><Reference><Citation>McCann EP, et al. Genetic and immunopathological analysis of CHCHD10 in Australian amyotrophic lateral sclerosis and frontotemporal dementia and transgenic TDP-43 mice. J Neurol Neurosurg Psychiatry. 2019 doi: 10.1136/jnnp-2019-321790.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2019-321790</ArticleId><ArticleId IdType="pubmed">31690696</ArticleId></ArticleIdList></Reference><Reference><Citation>Schindelin J, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9(7):676&#x2013;682. doi: 10.1038/nmeth.2019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.2019</ArticleId><ArticleId IdType="pmc">PMC3855844</ArticleId><ArticleId IdType="pubmed">22743772</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolte S, Cordeli&#xe8;res FP. A guided tour into subcellular colocalization analysis in light microscopy. J Microsc. 2006;224(3):213&#x2013;232. doi: 10.1111/j.1365-2818.2006.01706.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2818.2006.01706.x</ArticleId><ArticleId IdType="pubmed">17210054</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>